Furthermore, it is somewhat counterintuitive that soluble DLK1 appears to simultaneously promote glioma cell proliferation and stem cell characteristics, as it is widely assumed that stem-like cells display lower proliferation rates than more differentiated, non−stem-like cells. The gene discussed is DLK1; the disease is glioma.